Arylaminoethyl Amides as Novel Non-Covalent Cathepsin K Inhibitors
- 10 May 2002
- journal article
- letter
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 45 (12) , 2352-2354
- https://doi.org/10.1021/jm010801s
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Cathepsin K Knockout Mice Develop Osteopetrosis Due to a Deficit in Matrix Degradation but Not DemineralizationJournal of Bone and Mineral Research, 1999
- Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient miceProceedings of the National Academy of Sciences, 1998
- The Collagenolytic Activity of Cathepsin K Is Unique among Mammalian ProteinasesJournal of Biological Chemistry, 1998
- Cathepsin K, but Not Cathepsins B, L, or S, Is Abundantly Expressed in Human OsteoclastsJournal of Biological Chemistry, 1996
- Proteolytic Activity of Human Osteoclast Cathepsin KJournal of Biological Chemistry, 1996
- The gene for pycnodysostosis maps to human chromosome 1cen–q21Nature Genetics, 1995
- Molecular Cloning of Human cDNA for Cathepsin K: Novel Cysteine Proteinase Predominantly Expressed in BoneBiochemical and Biophysical Research Communications, 1995
- An asymmetric route to enantiomerically pure 1,2,3-trisubstituted cyclopropanesThe Journal of Organic Chemistry, 1992